by Editor | May 18, 2025 | Heart Disease Therapy, Procyon-Technologies News
Procyon Technologies was pleased to see the efficacy and viability of the iPSC-derived MSCs over 12 weeks while encapsulated in our proprietary immunoisolation devices. For more information, see https://www.biorxiv.org/search/10.1101%252F2025.04.01.646502. Cynata has...
by Editor | Jan 24, 2023 | Heart Disease Therapy, Procyon-Technologies News
A two-year grant from the Medical Research Future Fund’s Cardiovascular Health Mission will support a team led by St. Vincent’s Institute for Medical Research to develop a stem cell-based therapy for heart repair. For more information, see ...
